Kenneth Hung, MD, MS
Assistant Professor of Internal Medicine (Digestive Diseases); Associate Fellowship Program Director, Digestive Diseases
Research & Publications
Biography
News
Research Summary
My research interests are in quality improvement in patients hospitalized with gastrointestinal bleeding. During my gastroenterology fellowship at Columbia University Medical Center, I obtained a master's degree in patient-oriented research methods in the department of biostatistics at the Columbia Mailman School of Public Health. I studied factors associated with missed testing for Helicobacter pylori infection, a common cause of peptic ulcer disease. Based on my work on missed opportunities for H. pylori-associated peptic ulcer disease bleeding, I was awarded the top prize at the New York Society of Gastrointestinal Endoscopy annual meeting for a research poster.
Extensive Research Description
My initial research interest included optimizing donor and recipient matching in liver transplantation to improve post-transplant graft survival. I have published several manuscripts on outcomes of patients with cirrhosis and liver transplantation.
My most recent research interest involves measurement of quality of care and missed testing for Helicobacter pylori in patients hospitalized with bleeding peptic ulcer disease. H. pylori is a bacterium implicated in the development of gastric cancer and peptic ulcer disease. H. pylori testing and treatment are readily available and cost effective through a variety of modalities. H. pylori eradication significantly reduces the risk of recurrent bleeding from peptic ulcer disease. Despite strong evidence of the benefits of H. pylori testing and treatment, rates of H. pylori testing are low. I am studying the cascade of care among patients hospitalized with bleeding peptic ulcer disease to identify potential areas of intervention to increase H. pylori testing rates.
Coauthors
Research Interests
Gastrointestinal Hemorrhage; Peptic Ulcer Hemorrhage; Endoscopy, Gastrointestinal; Helicobacter pylori; Quality Improvement
Public Health Interests
Epidemiology Methods; Survival Analysis
Selected Publications
- AGA Institute Quality Indicator Development and Uses.Sheth SG, Maratt JK, Newberry C, Hung KW, Henry Z, Leiman DA, Quality Committee of the American Gastroenterological Association. AGA Institute Quality Indicator Development and Uses. Clin Gastroenterol Hepatol 2023, 21: 1399-1402. PMID: 36640806, DOI: 10.1016/j.cgh.2023.01.007.
- Deprescription of aspirin for primary prevention is uncommon at discharge in hospitalised patients with gastrointestinal bleedingLi D, Ong S, Hughes M, Hung K, Agarwal R, Alexis J, Damianos J, Sharma S, Pires J, Nanna M, Laine L. Deprescription of aspirin for primary prevention is uncommon at discharge in hospitalised patients with gastrointestinal bleeding. Alimentary Pharmacology & Therapeutics 2022, 57: 94-102. PMID: 36394111, DOI: 10.1111/apt.17278.
- S2444 Acute Esophageal Necrosis and Stricture Formation: A Case Report and Literature ReviewKapoor A, Saffo S, Hung K, Li D. S2444 Acute Esophageal Necrosis and Stricture Formation: A Case Report and Literature Review. The American Journal Of Gastroenterology 2022, 117: e1631-e1633. DOI: 10.14309/01.ajg.0000866416.76988.51.
- S656 Deprescription of Aspirin for Primary Cardiovascular Prophylaxis Is Rarely Performed at Discharge in Hospitalized Patients With Gastrointestinal BleedingLi D, Agarwal R, Hughes M, Ong S, Hung K, Alexis J, Damianos J, Sharma S, Laine L. S656 Deprescription of Aspirin for Primary Cardiovascular Prophylaxis Is Rarely Performed at Discharge in Hospitalized Patients With Gastrointestinal Bleeding. The American Journal Of Gastroenterology 2022, 117: e451-e452. DOI: 10.14309/01.ajg.0000859264.19614.40.
- S698 Bleeding Complications From Fecal Management Systems in the COVID Era: A Single Center ExperienceMcFarland M, Hung K, Li D, Hughes M. S698 Bleeding Complications From Fecal Management Systems in the COVID Era: A Single Center Experience. The American Journal Of Gastroenterology 2022, 117: e484-e485. DOI: 10.14309/01.ajg.0000859432.37885.a4.
- AGA Institute Quality Measure Development for the Management of Gastric Intestinal Metaplasia With Helicobacter pylori.Hung KW, Maratt JK, Cho WK, Shah BJ, Anjou CI, Leiman DA. AGA Institute Quality Measure Development for the Management of Gastric Intestinal Metaplasia With Helicobacter pylori. Gastroenterology 2022, 163: 3-7. PMID: 35337856, DOI: 10.1053/j.gastro.2022.03.023.
- Runaway Insufflation: Does Anesthesia or Spasm Hinder Insufflation During Colonoscopy?Hung KW. Runaway Insufflation: Does Anesthesia or Spasm Hinder Insufflation During Colonoscopy? Digestive Diseases And Sciences 2022 PMID: 35759157, DOI: 10.1007/s10620-022-07594-6.
- An Uncommon Cause of Coffee Ground Emesis in a Young Woman With Remote Roux-en-Y Gastric BypassMezzacappa C, Hughes ML, Hung KW. An Uncommon Cause of Coffee Ground Emesis in a Young Woman With Remote Roux-en-Y Gastric Bypass. Gastroenterology 2022, 163: e16-e17. PMID: 35490784, DOI: 10.1053/j.gastro.2022.04.032.
- Increased Mortality in Patients Undergoing Inpatient Endoscopy During the Early COVID-19 PandemicIlagan-Ying YC, Almeida MN, Kahler-Quesada A, Ying L, Hughes ML, Do A, Hung KW. Increased Mortality in Patients Undergoing Inpatient Endoscopy During the Early COVID-19 Pandemic. Digestive Diseases And Sciences 2022, 67: 5053-5062. PMID: 35182250, PMCID: PMC8857390, DOI: 10.1007/s10620-022-07414-x.
- Adapting to the Challenge of Hospital-Based Care: The Evolving Role of Gastroenterology HospitalistsHughes ML, Li DK, Hung KW, Laine L. Adapting to the Challenge of Hospital-Based Care: The Evolving Role of Gastroenterology Hospitalists. The American Journal Of Gastroenterology 2021, 117: 361-363. PMID: 34904965, DOI: 10.14309/ajg.0000000000001585.
- Impact of COVID-19 on gastroenterology fellowship training: a multicenter analysis of endoscopy volumesPaleti S, Sobani ZA, McCarty TR, Gutta A, Gremida A, Shah R, Nutalapati V, Bazerbachi F, Jesudoss R, Amin S, Okwara C, Kathi PR, Ahmed A, Gessel L, Hung K, Masoud A, Yu J, Mony S, Akshintala V, Jamil L, Nasereddin T, Kochhar G, Vyas N, Saligram S, Garg R, Sandhu D, Benrajab K, Konjeti R, Agnihotri A, Trivedi H, Grunwald M, Mayer I, Mohanty A, Rustagi T. Impact of COVID-19 on gastroenterology fellowship training: a multicenter analysis of endoscopy volumes. Endoscopy International Open 2021, 09: e1572-e1578. PMID: 34540553, PMCID: PMC8445682, DOI: 10.1055/a-1526-1419.
- Immune Checkpoint Inhibitor–associated Diarrhea and Colitis: A Systematic Review and Meta-analysis of Observational StudiesTran AN, Wang M, Hundt M, Chugh R, Ohm J, Grimshaw A, Ciarleglio M, Hung KW, Proctor DD, Price CC, Laine L, Al-Bawardy B. Immune Checkpoint Inhibitor–associated Diarrhea and Colitis: A Systematic Review and Meta-analysis of Observational Studies. Journal Of Immunotherapy 2021, 44: 325-334. PMID: 34380976, DOI: 10.1097/cji.0000000000000383.
- ReplyHung KW, Freedberg DE. Reply. Clinical Gastroenterology And Hepatology 2020, 19: 1298. PMID: 33249021, DOI: 10.1016/j.cgh.2020.07.037.
- The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study.Ramos GP, Dimopoulos C, McDonald NM, Janssens LP, Hung KW, Proctor D, Ruggiero E, Kane S, Bruining DH, Faubion WA, Raffals LE, Loftus EV, Al-Bawardy B. The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study. Inflammatory Bowel Diseases 2020, 27: 1270-1276. PMID: 33165569, DOI: 10.1093/ibd/izaa293.
- Su1852 EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASEDimopoulos C, Hung K, Proctor D, Ruggiero E, Al-Bawardy B. Su1852 EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE. Gastroenterology 2020, 158: s-675. DOI: 10.1016/s0016-5085(20)32379-9.
- Tu1786 IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED DIARRHEA AND COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIESTran A, Hundt M, Wang M, Ohm J, Chugh R, Grimshaw A, Hung K, Laine L, Al-Bawardy B. Tu1786 IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED DIARRHEA AND COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES. Gastroenterology 2020, 158: s-1160. DOI: 10.1016/s0016-5085(20)33574-5.
- 23 EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASEDimopoulos C, Hung K, Proctor D, Ruggiero E, Al-Bawardy B. 23 EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE. Gastroenterology 2020, 158: s32-s33. DOI: 10.1053/j.gastro.2019.11.107.
- 23 EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASEDimopoulos C, Hung K, Proctor D, Ruggiero E, Al-Bawardy B. 23 EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE. Inflammatory Bowel Diseases 2020, 26: s19-s20. DOI: 10.1093/ibd/zaa010.047.
- Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel DiseaseFaye AS, Hung KW, Cheng K, Blackett JW, Mckenney AS, Pont AR, Li J, Lawlor G, Lebwohl B, Freedberg DE. Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019, 26: 1394-1400. PMID: 31689354, PMCID: PMC7534414, DOI: 10.1093/ibd/izz269.
- 626 HAS-BLED Scores Underestimate Gastrointestinal Bleeding Risk Among Those With H. pyloriFaye A, Hung K, Cheng K, Parikh N, Knotts R, Freedberg D, Lebwohl B. 626 HAS-BLED Scores Underestimate Gastrointestinal Bleeding Risk Among Those With H. pylori. The American Journal Of Gastroenterology 2019, 114: s364-s364. DOI: 10.14309/01.ajg.0000592040.17612.c1.
- Factors Associated With Adherence to Helicobacter pylori Testing During Hospitalization for Bleeding Peptic Ulcer DiseaseHung KW, Knotts RM, Faye AS, Pont AR, Lebwohl B, Abrams JA, Freedberg DE. Factors Associated With Adherence to Helicobacter pylori Testing During Hospitalization for Bleeding Peptic Ulcer Disease. Clinical Gastroenterology And Hepatology 2019, 18: 1091-1098.e1. PMID: 31352090, DOI: 10.1016/j.cgh.2019.07.037.
- Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients With Inflammatory Bowel DiseaseFaye A, Hung K, Blackett J, Pont A, Lawlor G, Lichtiger S, Lebwohl B, Freedberg D. Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients With Inflammatory Bowel Disease. Gastroenterology 2019, 157: e24-e25. DOI: 10.1053/j.gastro.2019.05.019.
- 672 – Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease (Poster Presentation)Faye A, Hung K, Blackett J, Pont A, Lawlor G, Lichtiger S, Lebwohl B, Freedberg D. 672 – Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease (Poster Presentation). Gastroenterology 2019, 156: s-145. DOI: 10.1016/s0016-5085(19)37152-5.
- Adherence to Helicobacter pylori Testing After Hospitalization for Bleeding Peptic Ulcer DiseaseHung K, Abdelmessih R, Faye A, Pont A, Lebwohl B, Freedberg D. Adherence to Helicobacter pylori Testing After Hospitalization for Bleeding Peptic Ulcer Disease. The American Journal Of Gastroenterology 2018, 113: s628. DOI: 10.14309/00000434-201810001-01088.
- Predicting renal recovery after liver transplant with severe pretransplant subacute kidney injury: The impact of warm ischemia time.Laskey HL, Schomaker N, Hung KW, Asrani SK, Jennings L, Nydam TL, Gralla J, Wiseman A, Rosen HR, Biggins SW. Predicting renal recovery after liver transplant with severe pretransplant subacute kidney injury: The impact of warm ischemia time. Liver Transplantation : Official Publication Of The American Association For The Study Of Liver Diseases And The International Liver Transplantation Society 2016, 22: 1085-91. PMID: 27302834, DOI: 10.1002/lt.24488.
- Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.Hung K, Gralla J, Dodge JL, Bambha KM, Dirchwolf M, Rosen HR, Biggins SW. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics. Liver Transplantation : Official Publication Of The American Association For The Study Of Liver Diseases And The International Liver Transplantation Society 2015, 21: 1365-73. PMID: 25865434, DOI: 10.1002/lt.24138.
- The corrected donor age for hepatitis C virus-infected liver transplant recipients.Dirchwolf M, Dodge JL, Gralla J, Bambha KM, Nydam T, Hung KW, Rosen HR, Feng S, Terrault NA, Biggins SW. The corrected donor age for hepatitis C virus-infected liver transplant recipients. Liver Transplantation : Official Publication Of The American Association For The Study Of Liver Diseases And The International Liver Transplantation Society 2015, 21: 1022-30. PMID: 26074140, PMCID: PMC4809736, DOI: 10.1002/lt.24194.
- Dual therapy difficulties in angiotensin blockade for proteinuria: a teachable moment.Hung KW, Blaine J, Faubel S. Dual therapy difficulties in angiotensin blockade for proteinuria: a teachable moment. JAMA Internal Medicine 2014, 174: 1429-30. PMID: 25089763, DOI: 10.1001/jamainternmed.2014.3460.
- Rate and predictors of successful cardiopulmonary resuscitation in end-stage liver disease.Stotts MJ, Hung KW, Benson A, Biggins SW. Rate and predictors of successful cardiopulmonary resuscitation in end-stage liver disease. Digestive Diseases And Sciences 2014, 59: 1983-6. PMID: 24599771, DOI: 10.1007/s10620-014-3084-8.